NKE Truist downgrades to Sell from Hold, price target $29, citing weak innovation and Greater China headwinds offsetting margin recovery efforts.
Key data as of 10 Nov 2026
NKE Truist downgrades to Sell from Hold, price target $29, citing weak innovation and Greater China headwinds offsetting margin recovery efforts.
NKE reports after the close today with short interest near a multi-month peak, analysts still cutting targets, and the stock down 9.5% over the past month to $35.84. The short position has stabilised after a dramatic…
NKE arrives at its October 1 earnings with the most aggressive short-selling build in months — and, crucially, a lending market that has tightened meaningfully since the last note. The short position has grown sharply.…
NKE heads into its October 1 earnings report with short sellers adding aggressively, analysts cutting targets across the board, and the stock down 11% in a month — a setup that puts the recovery thesis under immediate…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for NKE — free to start on ORTEX.
Sign up for free →Open NKE on ORTEX